Cargando…

Preclinical Models of Neuroendocrine Neoplasia

SIMPLE SUMMARY: Neuroendocrine neoplasia comprise many distinct and rare subtypes of cancers. Preclinical models are essential for improving understanding of these diseases because clinical data is scarce. We review available preclinical models across a wide spectrum of neuroendocrine neoplasia (inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlack, Andrew J. H., Saleh-Anaraki, Kimia, Kumar, Suresh, Ear, Po Hien, Lines, Kate E., Roper, Nitin, Pacak, Karel, Bergsland, Emily, Quelle, Dawn E., Howe, James R., Pommier, Yves, del Rivero, Jaydira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688518/ https://www.ncbi.nlm.nih.gov/pubmed/36428741 http://dx.doi.org/10.3390/cancers14225646

Ejemplares similares

Preclinical Models of Adrenocortical Cancer
por: Sedlack, Andrew J. H., et al.
Publicado: (2023)

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation
por: Varghese, Diana Grace, et al.
Publicado: (2022)

Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
por: Maharjan, Chandra K., et al.
Publicado: (2021)

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
por: Jhawar, Sakshi, et al.
Publicado: (2022)

Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors
por: Varghese, Diana Grace, et al.
Publicado: (2023)

The Immunotherapy Landscape in Adrenocortical Cancer
por: Pegna, Guillaume J., et al.
Publicado: (2021)

SAT329 Case Series Of Patients With FGFR-1 Related Pheochromocytoma With A Focus On Biochemical And Imaging Signatures
por: Jhawar, Sakshi, et al.
Publicado: (2023)

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)

SAT555 Utility of (18)F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B
por: Varghese, Diana Grace, et al.
Publicado: (2023)

Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia
por: Dizdar, Levent, et al.
Publicado: (2016)

Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors
por: McClellan, Kristen, et al.
Publicado: (2022)

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
por: Viol, Fabrice, et al.
Publicado: (2022)

Animal models of pituitary neoplasia
por: Lines, K.E., et al.
Publicado: (2016)

Treatment Sequencing Strategies in Advanced Neuroendocrine Tumors: A Review
por: Chauhan, Aman, et al.
Publicado: (2022)

Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias
por: Sharma, Rohini, et al.
Publicado: (2021)

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes
por: Felder, S, et al.
Publicado: (2019)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

A Blood-Based Polyamine Signature Associated With Disease Progression in Patients With Multiple Endocrine Neoplasia Type 1-Related Duodenopancreatic Neuroendocrine Tumors
por: Fahrmann, Johannes F, et al.
Publicado: (2021)

Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias
por: Albers, Max B., et al.
Publicado: (2020)

Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
por: Walls, Gerard V., et al.
Publicado: (2016)

Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma
por: Shetty, Impana, et al.
Publicado: (2019)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

ARF sees Pdgfrβ through the miR
por: Reed, Sara M, et al.
Publicado: (2014)

The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
por: Schovanek, Jan, et al.
Publicado: (2014)

Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)

Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
por: Tonelli, Francesco, et al.
Publicado: (2012)

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
por: Abdelmalak, Rebecca, et al.
Publicado: (2021)

Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1
por: Marini, Francesca, et al.
Publicado: (2021)

Knife-assisted resection (KAR) for small rectal neuroendocrine neoplasia
por: Lisotti, Andrea, et al.
Publicado: (2020)

Pediatric Neuroendocrine Neoplasia of the Parathyroid Glands: Delving into Primary Hyperparathyroidism
por: Carsote, Mara, et al.
Publicado: (2023)

SAT-LB060 Clinical Presentation and Management of Primary Ovarian Carcinoids in Multiple Endocrine Neoplasia Type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

The role of DNA methylation in human pancreatic neuroendocrine tumours
por: English, Katherine A, et al.
Publicado: (2023)

FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy
por: Voigt, Ellen, et al.
Publicado: (2023)

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors
por: Ghosh, Raisa, et al.
Publicado: (2022)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
por: Bongiovanni, Alberto, et al.
Publicado: (2018)

Therapy of Patients with Neuroendocrine Neoplasia—Evidence-Based Approaches and New Horizons
por: Bundschuh, Ralph A., et al.
Publicado: (2019)

Anxiety, Depression and Quality of Life in Patients with Neuroendocrine Neoplasia After Surgery
por: Begum, Nehara, et al.
Publicado: (2022)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8b67gbv1sksalhb7n5o3duqdj